| Name | VPC-13789 | 
|---|
| Description | VPC-13789 is a potent, selective, and orally bioavailable antiandrogen. VPC-13789 can be used for the research of castration-resistant prostate cancer (CRPC) therapeutics. VPC-13789 inhibits androgen receptor (AR) transcriptional activity in LNCaP cells (IC50=0.19 μM)[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Molecular Formula | C21H16F3N3O | 
|---|---|
| Molecular Weight | 383.37 |